戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 a conserved and essential nuclear serine and threonine phosphatase.
2 ture-function studies of this protein serine/threonine phosphatase.
3  4 (PP4; also called PPX and PPP4), a serine/threonine phosphatase.
4 with protein phosphatase 2A (PP2A), a serine/threonine phosphatase.
5 catalytic subunit of a type 1 protein serine/threonine phosphatase.
6 t the activity of PP2A, another major serine/threonine phosphatase.
7 hosphatase and a protein phosphatase 2A-like threonine phosphatase.
8 trols a serine/threonine kinase and a serine/threonine phosphatase.
9 ovel PKC isozyme and a bFGF-dependent serine/threonine phosphatase.
10 losporin-sensitive, calcium-regulated serine/threonine phosphatase.
11  is a highly conserved and ubiquitous serine/threonine phosphatase.
12 during platelet aggregation activates serine/threonine phosphatases.
13  members of the PP2C class of protein serine/threonine phosphatases.
14 P2A) is a member of the intracellular serine/threonine phosphatases.
15 ut the expression and function of the serine-threonine phosphatases.
16 te with members of the PP2A family of serine/threonine phosphatases.
17 th calyculin A, a potent inhibitor of serine/threonine phosphatases.
18 A), an abundantly expressed family of serine-threonine phosphatases.
19 D was rapidly dephosphorylated by the serine-threonine phosphatase 1 alpha, and localized in the mito
20 on of mitotic FAK in vitro by protein serine/threonine phosphatase 1 restores the ability of FAK to a
21   In the cortex, mRNAs for neuronal tyrosine/threonine phosphatase 1, and microtubule-associated tau
22  of heat shock protein 90 and protein serine/threonine phosphatase 1-alpha.
23 otably, genetic disruption of protein serine/threonine phosphatase-1 (PP1) and its regulator NIPP1 de
24 n that regulates functions of protein serine/threonine phosphatase-1 in cell proliferation and lineag
25 in vivo evidence to show that protein serine/threonine phosphatase-1 is a major phosphatase that dire
26 ctive site is highly conserved in the serine/threonine phosphatase-1 subfamily, but not in the serine
27 P2R1A encodes a regulatory subunit of serine/threonine phosphatase 2, and ARID1A encodes adenine-thym
28 and is abolished by inhibition of serine and threonine phosphatase 2A (PP-2A).
29                               Protein serine/threonine phosphatase 2A (PP2A) activity must be tightly
30 ing experiments indicate that protein serine/threonine phosphatase 2A (PP2A) can dephosphorylate thes
31  indicates that regulation of protein-serine/threonine phosphatase 2A (PP2A) involves its association
32                               Protein serine/threonine phosphatase 2A (PP2A) is a critical regulator
33                               Protein serine/threonine phosphatase 2A (PP2A) is a multifunctional reg
34                               Protein serine/threonine phosphatase 2A (PP2A) regulates a wide variety
35 metric complex of CaMKIV with protein serine-threonine phosphatase 2A (PP2A) was identified in which
36 nase cascades, heterotrimeric protein serine/threonine phosphatase 2A (PP2A), is composed of catalyti
37 hown to stably associate with protein serine/threonine phosphatase 2A (PP2A), which was proposed to p
38 eral kinases and inhibited by protein serine/threonine phosphatase 2A (PP2A).
39 how that polyamine depletion inhibits serine/threonine phosphatase 2A (PP2A).
40 eam repressor COUP-TFII by inhibiting serine/threonine phosphatase 2A activity, and that decreased CO
41 nase 2 activity and increased protein serine/threonine phosphatase 2A activity, resulting in an incre
42 s control the activity of the protein serine/threonine phosphatase 2A catalytic subunit (PP2Ac), incl
43     Casein kinase 2 catalyzed protein serine/threonine phosphatase 2A phosphorylation thereby inhibit
44 asein kinase 2 complexed with protein serine/threonine phosphatase 2A.
45 n between casein kinase 2 and protein serine/threonine phosphatase 2A.
46 Sp1 binding via the action of protein serine/threonine phosphatase 2A.
47  EGCG can negatively regulate protein serine/threonine phosphatase-2A (PP-2A) to positively regulate
48 osphatase-1 subfamily, but not in the serine/threonine phosphatase-2A or -2B subfamilies.
49      The catalytic subunit of protein serine/threonine phosphatase 4 (PP4C) has greater than 65% amin
50 nd regulatory subunits of the protein serine/threonine phosphatase 4 complex (PP4c/PP4R1).
51 egulatory linkage between the protein serine-threonine phosphatase 5 (PP5) and ATM.
52                                       Serine/threonine phosphatase 5 (PP5) can act as a suppresser of
53 ding purple acid phosphatase, protein serine/threonine phosphatases, 5'-nucleotidase, and DNA repair
54 pitated c-Fos protein with the type 2 serine/threonine phosphatase A (PP2A) and immunoblotting of c-F
55  dephosphorylation through endogenous serine/threonine phosphatase action.
56 e transactivation, tyrosine phosphatase, and threonine phosphatase activities in their function as pa
57                Moreover, the PST/TPM and the threonine phosphatase activity are not required for in v
58 -free cell lysates, we find increased serine/threonine phosphatase activity associated with Golgi-enr
59             HOX11 also inhibited PP2A serine/threonine phosphatase activity concomitant with stimulat
60                                       Serine-threonine phosphatase activity dephosphorylated BAD in i
61 tination of proteins, we examined the serine/threonine phosphatase activity in our CAOV3 cells follow
62                        We also find that the threonine phosphatase activity plays only a minor role d
63  of Eya1 to the nucleus, where Eya1 uses its threonine phosphatase activity to control Myc phosphoryl
64  by KCC2 is completely independent of serine-threonine phosphatase activity, suggesting that these tw
65 een shown to have modest tyrosine and serine/threonine phosphatase activity, we find that it is much
66 mechanism whereby Ca(2+) can activate serine/threonine phosphatase activity.
67 lated c-Jun, and by the inhibition of serine/threonine phosphatase activity.
68 al kinase activity but to a decreased serine/threonine phosphatase activity.
69 ing PP1cgamma, a catalytic subunit of serine/threonine phosphatase, alpha(IIb)beta3 failed to dephosp
70                         Inhibition of serine/threonine phosphatases also enhanced sickle erythrocyte
71 tingly, okadaic acid, an inhibitor of serine/threonine phosphatase, also strongly activated transcrip
72 t protein phosphatase 1) is a protein-serine/threonine phosphatase and a negative regulator of the PI
73                      Loss of the PrpC serine-threonine phosphatase and the associated PrkC kinase of
74 ase C (PKC) activation, inhibition of serine/threonine phosphatase, and an active protein tyrosine ph
75 phatase-2A (PP2A), a widely expressed serine/threonine phosphatase, and the heterotrimeric G protein
76 ing several tyrosine phosphatases and serine/threonine phosphatases, and it suppresses the cell growt
77 applicable to other DUSPs and protein-serine/threonine phosphatases, and the substrate specificity da
78 otein phosphatase 2A (PP2A) family of serine-threonine phosphatases, and this interaction is required
79                               Protein serine-threonine phosphatases are assembled from catalytic subu
80              All of the known protein serine/threonine phosphatases are expressed in the brain.
81       The activity and specificity of serine/threonine phosphatases are governed largely by their ass
82         Members of the PP2A family of serine/threonine phosphatases are important human tumor suppres
83  phosphoprotein phosphatase family of serine/threonine phosphatases are thought to exist in different
84 osphatase-1 (PP1), a major eukaryotic serine/threonine phosphatase, are defined by the association of
85 ), potent and selective inhibitors of serine threonine phosphatases, are of interest for their antitu
86    In this review, we present protein serine/threonine phosphatases as viable therapeutic targets, di
87  cells, we identify PP2A as the first serine/threonine phosphatase associated with the multiprotein T
88 phatase 4 (PP4), a novel PP2A-related serine/threonine phosphatase, at a 50% inhibitory concentration
89 ined the regulatory interactions of a serine/threonine phosphatase (BA-Stp1), serine/threonine kinase
90 s the sequence hallmarks of a phospho-serine/threonine phosphatase belonging to the PPP family.
91 cells, it was determined that PP2A, a serine/threonine phosphatase, binds and dephosphorylates Rb2/p1
92 ase kinase-3-like kinase (BIN2) and a serine/threonine phosphatase (BSU1).
93                                   The serine-threonine phosphatase calcineurin (Cn)A plays a critical
94 1) cell cycle arrest, implicating the serine/threonine phosphatase calcineurin as one Ca(2+)/CaM-depe
95 ) and the Ca(2+)/calmodulin-activated serine/threonine phosphatase calcineurin exist and play a role
96                                   The serine/threonine phosphatase calcineurin is an important regula
97 e revealed that the calcium-dependent serine/threonine phosphatase calcineurin mediates the effects o
98 tion is modulated by Ca(2+)-dependent serine/threonine phosphatase calcineurin, an important target o
99 o explore the redox regulation of the serine/threonine phosphatase calcineurin, we have investigated
100 y of the calcium/calmodulin-dependent serine/threonine phosphatase calcineurin.
101 sphorylation by the calcium-dependent serine/threonine phosphatase calcineurin.
102 nals regulate MEF2 activity through a serine/threonine phosphatase calcineurin.
103 sphorylation are all modulated by the serine/threonine phosphatase calcineurin.
104 ecificity phosphatase (cdc25b), and a serine/threonine phosphatase (calcineurin).
105  discovered to be an inhibitor of the serine/threonine phosphatase, calcineurin, and its signaling pa
106  the calcium and calmodulin activated serine/threonine phosphatase, calcineurin.
107 and treatment of cRaf-1 with protein (serine/threonine) phosphatases can deactivate it, at least part
108 ent of CKIepsilon with any of several serine/threonine phosphatases causes a marked increase in kinas
109                 The mRNA encoding a tyrosine/threonine phosphatase (CL100/MKP-1) was also NO inducibl
110                         PP2A-B56 is a serine/threonine phosphatase complex that regulates several maj
111 (PP2A) is a family of multifunctional serine/threonine phosphatases consisting of a catalytic C, a st
112  (PP2A) is an abundant heterotrimeric serine/threonine phosphatase containing highly conserved struct
113 ation and PDZ-mediated formation of a serine/threonine phosphatase-containing complex by syndecan-4 a
114 in view of literature suggesting that serine/threonine phosphatases could be subject to redox control
115                           The protein serine/threonine phosphatase designated PP5 has little basal ac
116 phosphatases, including the family of serine/threonine phosphatases designated PP2A, is essential for
117                         Inhibition of serine/threonine phosphatases did not affect the activity of th
118  the dephosphorylation events via the serine/threonine phosphatases during the integrin outside-in si
119 nlike kinases, it remains unclear how serine/threonine phosphatases engage the signaling networks tha
120  ubiquitously expressed member of the serine-threonine phosphatase family that is involved in regulat
121 inases Cdk7 and Cdk9, whereas protein serine/threonine phosphatase FCP1 dephosphorylates CTD.
122    We have identified a novel type 2C serine-threonine phosphatase, FIN13, whose expression is induce
123 rprisingly, this structure revealed a serine/threonine phosphatase fold that unexpectedly targets tyr
124 omologue of the PPM family of protein-serine/threonine phosphatases found in all eukaryotes as well a
125 phatase 2A (PP2A) is one of the major serine/threonine phosphatases found in eukaryotic cells.
126 ene for a putative PPP family protein-serine/threonine phosphatase from the microcystin-producing cya
127 (ORFs) encoding two potential protein-serine/threonine phosphatases from the cyanobacterium Synechocy
128 inant for the targeting of the type 1 serine/threonine phosphatase (Glc7) to the bud neck.
129  phosphatase X (PPX)), a PP2A-related serine/threonine phosphatase, has been shown to be involved in
130                              Ptc1p, a serine/threonine phosphatase, has previously been shown to regu
131                Okadaic acid-sensitive serine/threonine phosphatases have been shown to regulate inter
132 ere we provide evidence that ppm-1, a serine/threonine phosphatase homologous to human PP2Calpha(PPM1
133                     The inhibition of serine/threonine phosphatases, however, has no effect on AChR r
134 tein phosphatase 2A (PP2A), the major serine/threonine phosphatase in eukaryotic cells, is a heterotr
135                        PTC1 encodes a serine/threonine phosphatase in the high-osmolarity glycerol re
136 r the involvement of a type 1 protein serine/threonine phosphatase in the ultraviolet radiation-induc
137     In this review, we concentrate on serine/threonine phosphatases in apicomplexan parasites, with t
138 nterference (RNAi)-based screening of serine/threonine phosphatases in Drosophila S2 cells, we identi
139 hosphatase 2A (PP2A), one of the main serine-threonine phosphatases in mammalian cells, maintains cel
140 ed distribution and lower activity of serine/threonine phosphatases in the context of HIV infection m
141 ed distribution and lower activity of serine/threonine phosphatases in the context of HIV infection m
142 vity of calcineurin, a Ca2+-dependent serine/threonine phosphatase, increases synaptic expression of
143 w that LTD expression is increased by serine/threonine phosphatase inhibition, and negatively regulat
144                                   The serine-threonine phosphatase inhibitor (OA) decreased NO releas
145 red for iNOS transcription, while the serine-threonine phosphatase inhibitor (OA) had no effect on iN
146 [PV], phenylarsine oxide [PAO]) and a serine-threonine phosphatase inhibitor (okadaic acid [OA]).
147 staglandin E(2), cAMP-raising agents, serine/threonine phosphatase inhibitor and activation of protei
148                                   The serine/threonine phosphatase inhibitor calyculin A (5 nM) sensi
149 e Ca(2+) ionophore ionomycin, and the serine/threonine phosphatase inhibitor calyculin A increased Se
150 s citrate and tartrate or the protein serine/threonine phosphatase inhibitor okadaic acid.
151 ated by treatment with calyculin A, a serine/threonine phosphatase inhibitor that elevates MLC phosph
152  kinases A and C, and okadaic acid (a serine/threonine phosphatase inhibitor) decreased the current c
153 -fibrinogen blocker) or okadaic acid (serine/threonine phosphatase inhibitor) dramatically enhanced E
154 t of eosinophils with okadaic acid, a serine/threonine phosphatase inhibitor, at the concentrations t
155 s, the tumor promoter okadaic acid, a serine-threonine phosphatase inhibitor, increased binding of ac
156 n by nickel; however, okadaic acid, a serine/threonine phosphatase inhibitor, induced Cap43 to a grea
157 n cells were lysed in the presence of serine/threonine phosphatase inhibitor, NaF, the PKA-enhancing
158 ere treated with okadaic acid (OA), a serine/threonine phosphatase inhibitor, to induce tau phosphory
159 ansport stimulated by okadaic acid, a serine/threonine phosphatase inhibitor, was also 45% lower with
160  KCC2 is completely resistant to this serine-threonine phosphatase inhibitor.
161                   The addition of the serine/threonine phosphatase inhibitors calyculin A and microcy
162 ivo skin and esophagus cultures, with serine/threonine phosphatase inhibitors causes a dramatic incre
163           Treatment of cells with serine and threonine phosphatase inhibitors had no effect on ankyri
164  cytosol, is resistant to the classic serine/threonine phosphatase inhibitors okadaic acid and microc
165 ment of cells with the cell-permeable serine/threonine phosphatase inhibitors okadaic acid or calycul
166 Treatment of erythroid cells with serine and threonine phosphatase inhibitors stimulated the hyperpho
167 el activation are inhibited by type 1 serine/threonine phosphatase inhibitors.
168 hibitor of type 1 and type 2A protein serine/threonine phosphatase, inhibits both receptor-induced ac
169 phatases modulate GPCR signaling, how serine/threonine phosphatases integrate with G protein signalin
170 oskeletal associated protein, proline serine threonine phosphatase interacting protein (PST PIP), via
171 ed in the identification of proline, serine, threonine phosphatase interacting protein (PSTPIP), a no
172 2BP1 and its murine ortholog, proline-serine-threonine phosphatase interacting protein (PSTPIP1), are
173 ology family protein PSTPIP2 (proline-serine-threonine phosphatase interacting protein 2), spontaneou
174 imilarity with the PST PIP (proline, serine, threonine phosphatase interacting protein)/CDC15 family
175 oskeletal-associated protein, proline-serine-threonine phosphatase-interacting protein (PSTPIP), whos
176 interaction between pyrin and proline serine threonine phosphatase-interacting protein 1 (PSTPIP1), t
177 ant missense mutations in the proline-serine-threonine phosphatase-interacting protein 1 gene (PSTPIP
178 e a curative option for other proline-serine-threonine phosphatase-interacting protein 1-associated i
179                               Proline-serine-threonine phosphatase-interacting protein 1-associated m
180 ry a missense mutation in the proline-serine-threonine phosphatase-interacting protein 2 (Pstpip2) ge
181      Missense mutation in the proline-serine-threonine phosphatase-interacting protein 2 (Pstpip2) ge
182   Missense mutation (L98P) of proline-serine-threonine phosphatase-interacting protein 2 (Pstpip2) in
183 ouse Lupo (I282N) mutation in proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2) le
184 ns of anti-inflammatory IL37, proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2), a
185  of the F-BAR domain protein, proline serine threonine phosphatase-interacting protein 2 (PSTPIP2), l
186              We now show that proline serine threonine phosphatase-interacting protein [PSTPIP1, or C
187 utations in the gene encoding proline serine threonine phosphatase-interacting protein-1 (PSTPIP1) ha
188 phatase 2A (PP2A) is a heterotrimeric serine/threonine phosphatase involved in essential cellular fun
189 osphatase-2A (PP2A) is a multisubunit serine/threonine phosphatase involved in intracellular signalin
190 ein phosphatase 2A, a family of major serine/threonine phosphatases involved in regulating cell proli
191  The multifunctional activity of many serine/threonine phosphatases is achieved through their associa
192 ein phosphatase 1 (PP1), a ubiquitous serine/threonine phosphatase, is a novel potent positive physio
193                        Calcineurin, a serine-threonine phosphatase, is activated by calcium and calmo
194  2A (PP2A) is an essential eukaryotic serine/threonine phosphatase known to play important roles in c
195 receptors such as CTLA-4 and CD28 and serine/threonine phosphatases may represent a novel mechanism f
196 ne-Threonine)-rich transactivation domain, a threonine phosphatase motif (TPM), and a tyrosine protei
197 ae, we isolated PTC2, which encodes a serine/threonine phosphatase of type 2C.
198  Addition of the inhibitor-of-protein serine/threonine phosphatases, okadaic acid, blocks the ATRA-me
199         Affinity isolation of protein serine/threonine phosphatases on the immobilized phosphatase in
200 alcineurin because inhibitors of this serine/threonine phosphatase partially rescue the block to adip
201  IRS1 and increased expression of the serine/threonine phosphatase Phlpp1.
202 by inducing the expression of the serine and threonine phosphatase Phlpp1.
203  PPM1A, a metal ion-dependent protein serine/threonine phosphatase, physically interacts with and dep
204 nduced activation of NF-kappaB, while serine-threonine phosphatases posttranscriptionally regulate iN
205                               Protein serine/threonine phosphatase (PP) 2A is a ubiquitous enzyme wit
206 lated with inhibition of the major Rb serine/threonine phosphatase PP1.
207 not significantly inhibit the protein serine/threonine phosphatases PP1 and PP2A.
208 activated inhibitor of type 1 protein serine/threonine phosphatase (PP1), in a yeast two-hybrid scree
209 tor that activates the type 1 protein serine/threonine phosphatase (PP1), which dephosphorylates eIF-
210                        Type-1 protein serine/threonine phosphatases (PP1) are uniquely inhibited by t
211 2) selectively inhibit type 1 protein serine/threonine phosphatases (PP1).
212 s of highly expressed skeletal muscle serine/threonine phosphatases (PP1, PP2A, PP2B, and PP2C) on AS
213 cal regulation of two major mammalian serine/threonine phosphatases, PP1 and PP2A.
214  stable and active complexes with the serine/threonine phosphatases PP1beta and PP1gamma, enzymes tha
215 racts with HDAC1, HDAC2, and with the serine-threonine phosphatase PP1CC.
216                     Inhibition of the serine/threonine phosphatase, PP2-A, with okadaic acid resulted
217 a was due, in part, to an increase in serine/threonine phosphatase PP2A activity.
218        Furthermore, we found that the serine/threonine phosphatase PP2A also regulates FoxO3a.
219 due to the combined activities of the serine/threonine phosphatase PP2A and the tyrosine phosphatase
220                      We find that the serine/threonine phosphatase PP2A can physically associate with
221 usly unrecognized requirement for the serine-threonine phosphatase PP2A in the function of T(reg) cel
222                 Alterations involving serine-threonine phosphatase PP2A subunits occur in a range of
223  family of tyrosine phosphatases, the serine/threonine phosphatase PP2A, and cholesterol.
224 hosphatase activity that contains the serine/threonine phosphatase PP2A, the tyrosine phosphatase HeP
225  is mediated by the activation of the serine/threonine phosphatase PP2A.
226 is dependent upon the activity of the serine/threonine phosphatase PP2A.
227  an inhibitor of the major PPP family serine/threonine phosphatases PP2A and protein phosphatase 1 (P
228 sed by SCF through phosphorylation of serine/threonine phosphatase (PP2A) and correlated well with fe
229 lated by a tightly associated protein serine-threonine phosphatase (PP2A).
230 mediated, in part, by type 2A protein serine/threonine phosphatases (PP2A).
231 ied with the main two subunits of the serine/threonine phosphatase, PP2A.
232 n a strain lacking functional type 2C serine/threonine phosphatases (PP2C), Ptc1 and Ptc3.
233                                   Two serine/threonine phosphatases, PP2Calpha and PP2A, were not sig
234 hysiological evidence for the protein serine/threonine phosphatase, PP5, as an effector of Rac GTPase
235                                   The serine/threonine phosphatase PPM1D/Wip1 inactivates p53 and pro
236 e show that the oncogenic p53-induced serine/threonine phosphatase, PPM1D (or Wip1), dephosphorylates
237 now identify a potential role for the serine-threonine phosphatase PPM1G in translational regulation
238         Selective inhibitors for each serine/threonine phosphatase (PPP) are essential to investigate
239 at identifies the PP2A heterotrimeric serine/threonine phosphatases PPP2R2A, PPP2R2D, PPP2R5A, and PP
240  regulation of okadaic acid-sensitive serine/threonine phosphatases; presumably, these phosphatases a
241 enes or the disruption of the general serine-threonine phosphatase protein phosphatase 2A (PP2A) can
242                                   The serine/threonine phosphatase protein phosphatase 2A (PP2A) play
243  the post-translational level, by the serine-threonine phosphatase protein phosphatase 2A (PP2A).
244                                   The serine/threonine phosphatase protein phosphatase 5 (PP5) regula
245 ) and gamma chain and also endogenous serine/threonine phosphatase protein phosphates 1 and/or 2A act
246 hibition of tyrosine phosphatases and serine/threonine phosphatases protein phosphatase 1 (PP1), PP2A
247 pproach, we have identified a protein serine/threonine phosphatase, protein phosphatase 2A (PP2A), as
248 down of Nqo1 enhanced activity of the serine/threonine phosphatase, protein phosphatase 2A, which ope
249 lso inactivated by treatment with the serine/threonine phosphatase, protein phosphatase 2A; okadaic a
250  Mycobacterium tuberculosis, only one serine/threonine phosphatase, PstP, has been identified.
251  SH2-B with protein phosphatase 2A, a serine/threonine phosphatase, reduces the many forms to two.
252                       Elucidating how serine/threonine phosphatases regulate kinase function and bact
253 rotein phosphatase 2A (PP2A), a major serine-threonine phosphatase, regulates similar biologic proces
254 n phosphatase 1 (PP1) is a ubiquitous serine/threonine phosphatase regulating many cellular processes
255 se I (PP1) is an essential eukaryotic serine/threonine phosphatase required for many cellular process
256 orylation pathway mediated by PKC and serine/threonine phosphatase(s).
257 r to be mediated by the activation of serine-threonine phosphatase, since they are blocked by low dos
258 m molybdate) but not by inhibitors of serine/threonine phosphatases (sodium fluoride, okadaic acid, a
259 e precise role of the co-transcribing serine/threonine phosphatase (SP-STP) has remained enigmatic.
260  important property of eukaryote-type serine/threonine phosphatase (SP-STP) of group A Streptococcus
261 he presence or absence of the cognate serine/threonine phosphatase Stp1 affects Stk1 function and GBS
262  mechanism was identified involving a serine/threonine phosphatase, Stp1.
263 id the taste, is dependent on several serine/threonine phosphatase substrates and the PP1-binding pro
264                                       Serine/threonine phosphatases such as PP1 lack substrate specif
265 nhibition of all known subfamilies of serine/threonine phosphatases, suggesting that multiple phospha
266                              PP5 is a serine/threonine phosphatase that also contains four copies of
267            Here, we identify PP1 as a serine/threonine phosphatase that associates with and dephospho
268 phosphatase 2A (PP2A) is a multimeric serine/threonine phosphatase that carries out multiple function
269                      Calcineurin is a serine/threonine phosphatase that contributes to the effects of
270 iments were performed to identify the serine/threonine phosphatase that dephosphorylates FOXO1.
271 p53-induced phosphatase 1 (WIP1) is a serine/threonine phosphatase that dephosphorylates proteins in
272 in is a calcium-calmodulin-regulated, serine-threonine phosphatase that functions as a key inducer of
273   Calcineurin is a calcium-dependent, serine/threonine phosphatase that functions as a signaling inte
274                      Calcineurin is a serine/threonine phosphatase that is activated by calcium and c
275  binds to and inhibits calcineurin, a serine/threonine phosphatase that is activated by TCR engagemen
276 hatase 2A (PP2A) is a multifunctional serine/threonine phosphatase that is critical to many cellular
277                    The Wip1 gene is a serine/threonine phosphatase that is induced in a p53-dependent
278 ylation of this site is mediated by a serine/threonine phosphatase that is inhibited by okadaic acid
279                      Calcineurin is a serine/threonine phosphatase that is inhibited by the immunosup
280 uced phosphatase PPM1D (or Wip1) is a serine/threonine phosphatase that is transcriptionally upregula
281 ates protein phosphatase 2A (PP2A), a serine/threonine phosphatase that modulates essential signaling
282 phosphatase 2A (PP2A) is an important serine/threonine phosphatase that plays a role in many biologic
283    Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that regulates a diverse array of
284 tein phosphatase 2A (PP2A) is a major serine/threonine phosphatase that regulates a wide variety of c
285 (Cn) is a Ca(2+)/calmodulin-dependent serine/threonine phosphatase that regulates differentiation-spe
286 n phosphatase 1 (PP1) is a ubiquitous serine/threonine phosphatase that regulates many cellular proce
287              PGAM5 is a mitochondrial serine/threonine phosphatase that regulates multiple metabolic
288  inhibited activity of calcineurin, a serine/threonine phosphatase that regulates NFAT activation.
289 B) is a calcium/calmodulin-activated, serine-threonine phosphatase that transmits signals to the nucl
290 se 2A (PP2A) is a family of mammalian serine/threonine phosphatases that is involved in the control o
291 ion of protein phosphatase 1 gamma, a serine/threonine phosphatase, to rat liver cytosol reduced acti
292 F appears to be mediated by a protein serine/threonine phosphatase type 1 or 2A.
293           A complete cDNA of a unique serine/threonine phosphatase type five (TbPP5) was cloned and c
294 se active site has been identified in serine-threonine phosphatases using a descriptor built from the
295 ed cancer genes was PPP6C, encoding a serine/threonine phosphatase, which harbored mutations that clu
296  belongs to the PPM family of protein serine/threonine phosphatases, which, in spite of a low level o
297 or protein phosphatase 2A (PP2A) is a serine/threonine phosphatase whose activity is inhibited in mos
298  phosphatase-2A (PP2A) is an abundant serine/threonine phosphatase with anti-inflammatory activity.
299 PX or PPP4) is a PP2A-related protein serine/threonine phosphatase with important roles in a variety
300 ontains a mutation in PTC1, a type 2c serine/threonine phosphatase with widespread influences.

 
Page Top